The peptide problem: Hype is outrunning the evidence FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling The Unregulated World of Peptides: A Legal Minefield for Providers Holt Law The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Deep Dive: Regulatory Status of Popular Compounded Peptides Holt Law FDA Is Expected to Lift Restriction on Peptides, Heeding RFK Jr.'s Wishes The New York Times